We are live on ! Find out more
NTGN

Neon Therapeutics, Inc. Common Stock
NTGN

Delisted

NTGN was delisted on the 5th of May, 2020.

Back to rankings

41 hedge funds and large institutions have $233M invested in Neon Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
0.94%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
+$133M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$32.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.3M
4
PHS
PFM Health Sciences
California
+$13.3M
5
HIM
Hillhouse Investment Management
Cayman Islands
+$9.75M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$298K +$324K +23,662 New
BCPEM
27
Bain Capital Public Equity Management
Massachusetts
$147K +$160K +11,706 New
Northern Trust
28
Northern Trust
Illinois
$137K +$149K +10,885 New
HCMT
29
Highland Capital Management (Texas)
Texas
$137K +$149K +10,894 New
PHK
30
Point72 Hong Kong
Hong Kong
$105K +$114K +8,302 New
AAMU
31
Amundi Asset Management US
Massachusetts
$63K +$68.5K +5,000 New
Coatue Management
32
Coatue Management
New York
$63K +$68.5K +5,000 New
Morgan Stanley
33
Morgan Stanley
New York
$42K +$45.2K +3,304 New
CSS
34
Cubist Systematic Strategies
Connecticut
$32K +$34.2K +2,500 New
PIM
35
Partner Investment Management
California
$32K +$34.5K +2,522 New
HIIFS
36
Harel Insurance Investments & Financial Services
Israel
$13K +$13.7K +1,000 New
Wells Fargo
37
Wells Fargo
California
$13K +$13.7K +1,000 New
Bank of America
38
Bank of America
North Carolina
$13K +$14.6K +1,069 New
JCM
39
Jacobi Capital Management
Pennsylvania
$6K +$6.85K +500 New
CCA
40
Catalyst Capital Advisors
New York
$4K +$4.82K +352 New
IUHSA
41
Itau Unibanco Holding S.A.
Brazil
$3K +$3.7K +270 New
UBS Group
42
UBS Group
Switzerland
– +$479 +35 New
1
2

NTGN Hedge Fund Activity: Q2 2018 in Review

41 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Neon Therapeutics, Inc. Common Stock (NTGN) for Q2 2018, worth a combined $233M.

Buyers outnumbered sellers: 41 funds opened new NTGN positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TRV GP III, opening a new position worth an estimated $133M.

  • 41 institutional investors held Neon Therapeutics, Inc. Common Stock (NTGN) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $233M of Neon Therapeutics, Inc. Common Stock stock for Q2 2018.
  • 41 funds opened new Neon Therapeutics, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +41 holders.
  • The largest Neon Therapeutics, Inc. Common Stock buyer in Q2 2018 was TRV GP III, an estimated $133M added.

Based on aggregated 13F filings for Q2 2018.